Drug & intervention

auranofin

RxCUI 1227

Clinical trials5
Recruiting1
Related conditions13
Synonyms11

Understanding this RxNorm record

RxNorm identifiers distinguish ingredients, specific strengths, dose forms, and branded products. They help connect equivalent terminology across data sources; an RxNorm entry does not by itself establish that a product is currently marketed, approved for a particular use, or appropriate for an individual.

Clinical-trial associations reflect registry-reported intervention names and verified mappings where available. A medication listed in a trial may be investigational for that condition. Consult the original study record and official prescribing information for indications and safety details.

Terminology source: National Library of Medicine RxNorm. Trial source: ClinicalTrials.gov.

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Auranofin

Auranofin is an orally administered gold salt classified by the World Health Organization as an antirheumatic agent. It has the brand name Ridaura. Along with sodium aurothiomalate, it is one of only two gold compounds currently employed in modern medicine.

Read on Wikipedia ↗ Wikidata Q421230 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

5 shown
Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without AntiretroviralsNCT06805656 · 2026-07-15
RECRUITING
Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing CureNCT02961829 · 2015-07-01
COMPLETED
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung CancerNCT01737502 · 2014-05-14
COMPLETED
Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerNCT02126527 · 2013-08-01
WITHDRAWN
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV InfectionNCT02176135
WITHDRAWN

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.